Acute ultraviolet light B (UVB) injury is associated with dermal mast cell histamine release. The possibility that histamine-stimulated prostaglandin (PG) synthesis could be a mechanism for irradiation erythema was therefore examined using human skin explants. Explants responded to UV irradiation (120 mJ/cm2) with a fivefold increase in synthesis of prostaglandins E2, F2 alpha and 6-keto PGF1 alpha. Incubating explants with the H1 antihistamines brompheniramine (50 microM) or pyrilamine (30 microM) inhibited PG release from irradiated explants 63 +/-4.9% (mean +/-SEM) 6 h after UV exposure. Antihistamines did not affect PG synthesis in control explants. Irradiation increased the histamine concentration in explant conditioned medium only 50% over basal values, suggesting that irradiation enhanced histamine responsiveness. Explants were therefore incubated with exogenous histamine. In irradiated explants, PG synthesis was stimulated threefold by 3 microM histamine. Unirradiated explants' PG synthesis was unaffected by histamine. Enhanced histamine sensitivity was also examined in epidermal cell cultures. In irradiated cultures, histamine sensitivity was again markedly potentiated: as little as 1 microM histamine stimulated significant PGE2 release and the response to 10-30 microM histamine was increased six to eight times compared with that of unirradiated cultures. These studies demonstrate that endogenous histamine stimulates PG synthesis in human skin after UV injury by potentiation of histamine-induced prostaglandin release. 
Introduction
The biologic effects of ultraviolet light B (UVB)' on the skin are of particular interest because of the importance of UV-in-duced injury in the development of photoaging and skin cancer (1) and the role of UV irradiation in the therapy of skin disease (2) . The precise mechanism(s) for the effects of UVB on tissue are poorly understood, but one ofthe most common manifestations of UVB injury of the skin is erythema.
Current evidence for a role for arachidonate metabolism in UV-induced erythema includes the correlation of increased metabolite formation with the development of erythema and erythema reduction by selective inhibitors. For example, significant elevations of arachidonic acid and its cyclooxygenase and lipoxygenase products are observed in dermal perfusates and in suction blisters raised on irradiated skin (3) (4) (5) , and inhibition of cyclooxygenase-derived prostaglandins by indomethacin treatment blocks 50% of the erythema that develops during the first 24 h after UVB injury (3, (8) (9) (10) (11) (12) . Studies of UV-irradiated keratinocytes. suggest that the elevated levels of prostaglandins generated after irradiation might be due to increased synthesis and/or activity of the cyclooxygenase enzyme by 24 h after exposure (13) . However, erythema in vivo is associated with increased quantities of prostaglandins 3-6 h after irradiation (1, 4, 5) . Thus, the basis for increased prostaglandin synthesis during the early phase of erythema is uncertain.
One possible mechanism for the early increases in prostaglandin levels in UVB-induced erythema comes from the finding that dermal mast cells are also activated 3-6 h after irradiation, resulting in degranulation and histamine release (4, 14, 15) . We speculated that histamine might in turn stimulate arachidonate metabolism in the skin, and furthermore that an increased response to histamine after UV irradiation might result in enhanced generation of prostaglandins.
The current studies were designed to determine if endogenous histamine release in UV injury induces prostaglandin synthesis in human skin. The histamine-dependent arachidonate metabolism of isolated human keratinocytes before and after UVB irradiation was also studied to assess whether UV injury alters the cellular response to histamine. Our finding that cells acquire the capacity to synthesize prostaglandin in response to endogenously released histamine after UV injury demonstrates that histamine-stimulated prostaglandin synthesis is an underlying mechanism in the early phase of the human erythema response.
Methods
Preparation ofhuman skin explants. Explants were prepared from pale white full thickness human skin obtained from panniculectomies. To make explants, the dermis was trimmed using a scalpel, leaving tissue 1-1.5-mm thick and weighing 0.1 g. Histologically, explants consisted of superficial dermis, superficial vascular plexus, and epidermis. All explant data was collected in quadruplicate. The wet weight of the tissue was measured to determine the protein content of the explants.
Because the trauma during preparation might produce mast cell degranulation, studies were begun 18 h after trimming, to allow mast cells to refill histamine stores (4, 15) . After setting up explants, they were maintained at 370C in a 5% CO2 atmosphere. 18 h after the explants were cut, they were exposed to 120 mJ/cm2 UV. This dose of light represents three to four times the minimal erythema dose of the average individual with pale white skin exposed to Westinghouse FS20 lamps (Westinghouse Electric Corp., Pittsburgh, PA) (2). In preliminary experiments, this dose of light was tested in individuals whose skin was pale white. The erythema reactions produced ranged in severity from erythema lasting only 24 h to deep erythema which persisted for 3 d, accompanied by transient edema at 24 h. Explants examined for morphologic effects of UV light were fixed in formalin, embedded in paraffin, cut into sections and stained with either hematoxylin and eosin or giemsa (for studies of mast cell number and morphology).
Preparation of keratinocyte cultures. Skin tissue was defatted and placed on gauze soaked in 0.25% trypsin in PBS. After incubation at room temperature overnight, the skin was rinsed in DME containing 5% FCS, 5 U/ml penicillin and 5 gg/ml streptomycin. The epidermis was separated from the dermis with forceps, and the epidermal cells scraped into DME containing 5% FCS, penicillin, streptomycin and 2.5 mM Hepes (pH 7.4). Isolated cells were placed into 22-or 100-mm dishes coated with collagen solution (Vitrogen; Flow Laboratories) diluted in PBS ( 1:3 vol/vol) at a density of 7.5 X I05 cells/cm2. Cultures were used for experiments 3-4 d after reaching confluence. Experiments were also carried out using passaged keratinocytes. Passaged cells were maintained as described previously (16) . These culture conditions do not promote the growth of melanocytes or Langerhans cells, so passaged keratinocytes are relatively free from contamination by other epidermal cell types (17) .
Irradiation of explants and keratinocyte cultures. Explants were exposed to a bank of eight FS-20 bulbs (Westinghouse), which emit light predominantly in the UVB range, 290-320 nm, but also emit some longer and shorter wavelengths (2) Radioimmunoassays. PGE2, PGF2a, PGD2, TXB2, 6-keto-PGF1a, 12S-HETE, and 1 5-HETE were determined in the supernatants from cultured cells by RIA as previously described (22) . Antibodies to PGE2, 6-keto-PGFIa, LTC4, and TXB2 were the gift of Philip Needleman (Washington University). Antibody to PGF2a, PGD2, 12S-HETE and 1 5-HETE was purchased from Advanced Magnetics, Cambridge, MA. The limits ofdetection by RIA were: 2 pg for PGE2, 74 pg for PGD2, 2 pg for PGF2a,, 1.5 pg for TXB2, 10 pg for 6-keto-PGF1,, 17.2 pg for LTC4, 300 pg for 12-HETE, and 24 pg for 1 5-HETE. Cross-reactivities ofthe antibodies were < 1%, except for the 12S-HETE antibody, which cross-reacts 10% with 12R-HETE, and for the PGD2 antibody, which cross-reacts 2.75% with 6-keto-PGE,. Treatment ofthe explants with 1 jig/ml indomethacin at the time of preparation completely inhibited prostaglandin synthesis. Histamine was assayed by competition of acylated histamine and '25I-acylated histamine (AMAC, Inc., West- brook, ME). The limit of detection of the assay is 1 nM.
Protein determinations. Metabolite levels were expressed per amount of total cell protein. The quantity of protein was determined by the fluorescamine method using BSA as a standard (23) . UV irradiation of the cultures did not result in a significant change in their protein content.
Results
UV irradiation enhances release of eicosanoid metabolites from skin explants. In vivo, the erythema induced by UV exposure is dose-related and dependant upon skin color (1, 2) . Initial studies were done to correlate the UV-stimulated prostaglandin release in explants with the pattern of UV erythema in vivo. UV exposure (30-180 mJ/cm2) induced a dose-dependant increase in cumulative PGE2 release from explants during the first 6 h after UV exposure (Fig. 1 ). The effect of skin color on UV-stimulated prostaglandin synthesis by explants was also studied in several experiments using black skin. When black skin explants were irradiated, no significant stimulation of PGE2 synthesis was observed (6.2±1.3 ng/g per h in controls versus 6.7+1.5 ng/g per h after UV irradiation), conEndogenous Histamine Stimulates Prostaglandin Synthesis sistent with the observation that black individuals can tolerate exposure to 120 mJ/cm2 UV without developing erythema (2) .
Radioimmunoassay was used to determine the range of eicosanoids released. PGE2, PGF2a, and PGI2 (measured as its stable metabolite 6-keto-PGFIa) were the prostaglandins synthesized in the greatest quantity (Table I) . PGE2 release by explants 6-7 h after irradiation was increased 5.5±0.83-fold over that of unirradiated tissue. An even greater increase in PGF2. release was induced by irradiation (7.3±1.4-fold), whereas release of 6-keto PGF1,, was stimulated only 3.4±1.4-fold. Exogenous prostaglandin was added to indomethacintreated cultures to determine the effect of UV exposure on prostaglandin degradation. No difference was observed in the quantity of material degraded over a 2-h interval, as determined by RIA. The increase in prostaglandins detected was therefore due to new synthesis, and not decreased breakdown of prostaglandin. 12-HETE was also detected in some experiments, but was present at levels near the limit of detection of the assay, so it was not possible to determine the effect of UV exposure on the synthesis of this metabolite. LTC4, PGD2, TXA2 (measured as TXB2) and 15-HETE were not detected. Therefore, in subsequent experiments, PGE2, PGF2a, and 6-keto PGF1, were the metabolites monitored to document the changes in prostaglandin release induced by UV exposure. HI receptor blockers decrease UV-induced prostaglandin synthesis in human skin. The possible stimulation of explant prostaglandin synthesis by endogenous histamine release was examined by incubation of the explants with HI and H2 histamine receptor blockers. Pretreatment of the explants with the HI receptor antagonist brompheniramine (50 MM) resulted in a 63±4.3% inhibition of prostaglandin release from the explants (mean±SEM, n = 6, P . 0.02) (Fig. 2) . A 30% inhibition of the UV-stimulated prostaglandin release also occurred in explants incubated with 30 MM pyrilamine, an HI antagonist from a different chemical class. Despite the significant inhibition ofprostaglandin synthesis by HI antagonists in irradiated explants, no effect on prostaglandin synthesis of control explants was observed. The suppression of prostaglandin release produced by HI receptor blockers slowly increased over the 8-h period of observation (Fig. 2) . The effect of antihistamines on explant prostaglandin synthesis was further examined by incubating explants with doses of brompheniramine ranging between 5 and 100 MM. A dose-dependent inhibition of PGE2, PGF2a, and 6-keto PGFIa release was again observed only in irradiated explants (Fig. 3) . Treatment of irradiated explants with as little as 10 MM brompheniramine resulted in a 50% inhibition of prostaglandin release. The decrease in prostaglandin release induced in antihistaminetreated explants was not a toxic effect, since prostaglandin release could be stimulated by 1 MM bradykinin, but not 10 MM histamine (Fig. 4) . In contrast to the effectiveness of the Hi antagonists in suppressing prostaglandin synthesis, incubation of the explants with 30 AM of the H2 antagonist cimetidine did not change prostaglandin synthesis (Fig. 5) .
Increased prostaglandin release results primarily from increased agonist sensitivity, not increased histamine release. Since endogenous histamine release was apparently responsible for stimulating increased prostaglandin release in the first 8 h after UV injury, the quantity of histamine present in the conditioned media of the explants was measured by radioimmunoassay. 6 h after UV exposure 35.7±4.5 nM histamine was detected in the medium from irradiated explants, while 23.4±2.8 nM was detected in medium from controls (n = 6). Although some increase in the quantity of histamine released from explants did occur, most intriguing was the finding that despite a significant concentration ofhistamine in the medium of control explants, their prostaglandin synthesis was not increased by histamine.
This observation was further examined by incubating explants with 1 to 10 MM exogenous histamine then determining the quantity ofprostaglandin released. Prostaglandin release in irradiated explants incubated with 3 MM histamine was increased threefold, whereas control explants release of prostaglandin increased only minimally when incubated with 10 AM histamine (Fig. 6) . Thus, while endogenous histamine release is important to stimulate prostaglandin synthesis, an increase in sensitivity to histamine also contributes to the increased prostaglandin synthesis that occurs.
UV irradiation causes increased histamine responsiveness in epidermal cultures. Since the majority of the light entering the skin is absorbed by the epidermis, epidermal cell cultures were prepared to study the mechanism of enhanced histamine responsiveness that appeared in irradiated explants. Analysis of supernatants from histamine-stimulated keratinocytes by HPLC and RIA demonstrated that PGE2 was the predominant metabolite: PGE2 release was markedly increased after UV irradiation, as was observed in irradiated explants. In unirradiated keratinocyte cultures, significant release of PGE2 was detected only after stimulation with the highest concentration of histamine (30 ,M) and the level of release was so low that it was detectable by RIA but often not by HPLC (Figs. 7 and 8 ). In contrast, keratinocyte cultures exposed to 30 mJ/cm2 of UV light became responsive to lower concentrations of histamine and generated larger amounts of PGE2 at all concentrations tested (Fig. 8) higher levels than the maximal amounts from unirradiated control cultures (Fig. 8 ). This pattern of increased histamine sensitivity was identical to that observed in histamine-stimulated irradiated explants. Despite the increased sensitivity to histamine, no significant increase in the basal accumulation of PGE2 was detected during the 6 h between irradiation and histamine stimulation.
Reverse-phase HPLC analysis of the radiolabeled metabolites released by irradiated keratinocytes demonstrated that, in addition to PGE2 the largest peak of activity corresponded to arachidonic acid itself and that the quantity of both was increased by UV irradiation (Fig. 7) . The degree of increase for PGE2 determined by HPLC was similar to the change detected by RIA, and the increase in the level of arachidonic acid was consistent at a mean value of 20% above control (n = 3). Analysis of supernatants from irradiated keratinocytes also revealed a smaller peak of radiolabeled material which corresponded to the retention time of PGF2a, but no evidence of generation of HETEs, leukotrienes, or epoxides (Fig. 7) . The presence of PGF2. and its increase after UV irradiation were substantiated by determinations using RIA, which exhibited a mean increase of five times in irradiated compared to control cultures (data not shown). 30 mJ/cm2 (Fig. 9) . Doses of light lower than 30 mJ/cm2 did not affect histamine-stimulated PGE2 release, but cultures exposed to Mj/CM2 exhibited a marked increase in 'release: supernatants from irradiated cultures contained three to four times as much PGE2 as cultures exposed to lower amounts of UV light. The development of histamine responsiveness after exposure of 30 mJ/cm2 was observed as early as 1 h after irradiation and was maximal by 3-6 h (Fig. 10) , in a pattern identical to the brompheniramine-suppressible prostaglandin release of the explants. Increased responsiveness was still present up to 72 h after exposure to UV light.
UV-induced morphologic changes. Despite the marked enhancement of histamine-stimulated arachidonate metabolism after UV exposure, neither explants nor irradiated keratinocyte cultures showed evidence of morphologic changes by phase microscopy. When cultures were examined 6 h after UV irradiation with 30 mJ/cm2, the appearance of irradiated cul- tures was indistinguishable from that ofcontrol cultures. However, by 24 h after exposure to this dose of UV light, the irradiated cells exhibited mild cytoplasmic vacuolization and swelling, without loss of adherence, cell lysis or dyskeratosis (Fig. 11) . Explants fixed in formalin, sectioned and stained with either hematoxylin and eosin or Giemsa showed no morphologic change or change in mast cell number or granularity.
Although the changes in histamine-stimulated PGE2 release from cultured keratinocytes were similar at 30, 45, and 60 mJ/cm2, only the two highest doses of UV light caused patchy areas of necrosis by 24-48 h after irradiation. Even at the highest doses of light, no changes in cell morphology were evident 6 h after irradiation.
HI receptors mediate the histamine response. Inhibition with selective antagonists suggested that the receptor that mediated the histamine response in cultured keratinocytes was of the H 1 type. Cultures incubated with the H 1 antagonist pyrilamine no longer responded to histamine, but those that were pretreated with the H2 antagonist cimetidine exhibited no significant change in histamine-stimulated PGE2 release (Table  II) . Thus, H 1 receptors are linked to release and oxygenation of arachidonic acid in human keratinocytes.
Cyclooxygenase activity is not increased by UVirradiation. The possibility that the increase in PGE2 synthesis after UVirradiation was due to an increase in cyclooxygenase activity was examined by assaying control and irradiated cells for maximal cyclooxygenase activity. Cells that were UV-irradiated 6 h before study generated no more PGE2 when incubated with exogenous arachidonic acid (20 gM for 15 min) than did unirradiated cultures.
Protein synthesis is required for UV-potentiated PGE2 release. To further examine the mechanism of the enhanced responsiveness to histamine, the effect of inhibiting protein synthesis with cycloheximide was examined. Addition of cycloheximide 5 ug/ml immediately after irradiation blocked increased synthesis of PGE2 in response to histamine but did not significantly alter basal PGE2 release (Table III) .
[3H]Leucine incorporation into acid-precipitable protein was monitored to document the effectiveness of cycloheximide treatment. An 80% inhibition of protein synthesis occurred using this dose of drug. Of note is the observation that UV exposure did not alter the total incorporation of [3H]leucine into protein after 6 h, so the protein synthesis required for the increased response to histamine is not accompanied by an overall increase in cellular protein synthesis.
Discussion
The results show that UV irradiation increases prostaglandin synthesis in human skin explants through endogenous histamine stimulation. This implies an important role for histamine in mediating UV erythema, since the role of prostaglandins in mediating UV erythema is well established (3, (8) (9) (10) (11) (12) . Several aspects of the data collected support this conclusion. Suppression of prostaglandin synthesis was specific and receptor mediated since blockade ofhistamine receptors using drugs from two different chemical classes was effective in decreasing prostaglandin release in irradiated explants, while the H2 antagonist cimetidine was ineffective. In addition, bradykininstimulated prostaglandin release could occur in the! presence of the HI receptor blocker brompheniramine. This antihistamine-suppressible component of UV-stimulated prostaglandin synthesis also occurs at the same time that UV-induced mast cell degranulation takes place, and increased quantities of histamine have been measured in suction bullae raised on irradiated skin (4) . Taken collectively, this evidence implicates histamine as an important mediator of UV-stimulated prostaglandin synthesis in vivo.
Another important observation is the discovery that UV exposure decreases the threshold for histamine stimulation in irradiated skin. Irradiation enables the explant to respond to the concentration of histamine actually present in the tissue. This is demonstrated by the observation that the prostaglandin synthesis of unirradiated explants bathed in nearly the same concentration of histamine as irradiated explants is not affected by the presence of the agonist. An irradiation-induced decrease in the threshold and increase in the magnitude of histamine-stimulated PGE2 synthesis was also found in cul-0.6 tured human keratinocytes. Therefore, the change induced by UV exposure is not just mediator release, but an increase in the capacity of irradiated tissue to respond. The time course of the onset of increased histamine sensitivity in the epidermal cultures corresponds well with the observed onset of UVB erythema (3-6 h after UVB irradiation) (1, 4, 5) , and with the onset of brompheniramine-suppressible prostaglandin synthesis by irradiated explants. Taken collectively, these observations strongly support the role of histamine-induced prostaglandin synthesis in the response to UV light in vivo.
The underlying mechanism of the increased agonist responsiveness induced by UV injury remains to be defined. New protein synthesis is required, because cycloheximide blocked the increase in histamine sensitivity. This suggests an increase in the quantity of the enzymes leading to synthesis of prostaglandin, or in the receptor-linked signal transduction apparatus regulating their function. A change in the synthesis or degradation of cyclooxygenase is not implicated, since cyclooxygenase activity was not increased in the irradiated cultures. Enhanced prostaglandin synthesis due to increased phospholipase activity is likely since increased release of labeled arachidonic acid in histamine-stimulated irradiated cultures was present. UV-induced lipid peroxidation (24, 25) may contribute to this increase in phospholipase activity since phospholipase stimulation and inhibition of fatty acid reacylation have been demonstrated in tissues suffering from peroxidation injury (26) (27) (28) .
Cytokines such as IL-1, tumor necrosis factor, and IL-6, which are synthesized by epidermis and which are released in skin l4y UV exposure (29) may play a role in mediating irra- pressible with antihistamines (12, 33) , suggesting it is mediated by histamine. In rats, a histamine-suppressible component of UVB-induced erythema occurs during the later, peak erythema phase (33) . In humans, evidence demonstrating a role for histamine in UV erythema is equivocal. In one study by Partington, no effect was found, but the effectiveness of the antihistamine was documented only by its ability to suppress histamine-induced vasodilation (34) . In this series of experiments, the histamine receptor ofepidermis may not have been adequately blocked. An extended preincubation with antihistamine was found to be useful in our experimental system (data not shown). In contrast to these findings, a trial of triprolidine to reduce UVB erythema in patients with several photosensitivity dermatoses produced a significant benefit (35) . The data presented here suggest the importance of histamine-stimulated prostaglandin release as an endogenous mediator of UV erythema in humans. The realization that increased sensitivity of irradiated tissue to histamine occurs after UV exposure will facilitate design of rational drug therapy for UV injury.
Acknowleda-ments diation erythema. However, use of recombinant IL-1, IL-6, and tumor necrosis factor did not reconstitute enhanced histamine sensitivity in cultured keratinocytes (Pentland, A., unpublished observations). Other polypeptide mediators not yet identified may still induce the keratinocyte response. In addition, these cytokines may be very important at later time points in the irradiation response. Our results differ in one aspect from previous studies of UVB-induced injury carried out in vivo in that we did not find evidence of 12-HETE generation in the cultured cells in response to UV irradiation. Cultured keratinocytes exhibit little evidence of the monooxygenase pathway responsible for 12-HETE generation (unpublished observations by Holtzman and Pentland), which is expressed at a high level in freshly isolated epidermal cells (21). Explanations for differences between freshly isolated and cultured cell oxygenation pathways include the loss ofa subset of epidermal cells during culture or an alteration in the expression of keratinocyte oxygenation pathways during growth in artificial media. Determinations of factors that regulate expression of oxygenation enzymes are currently under investigation. The absence of consistently detectable quantities of 12-HETE in the explants is most likely due to the poor sensitivity of the RIA available. More work will be needed to define whether the synthesis of this metabolite is also stimulated by endogenous agonists in skin.
The data also clarify previous work examining histamine responses in the skin. While increased prostaglandin synthesis has been demonstrated in histamine-stimulated whole skin (30) , the capacity of isolated keratinocytes to synthesize prostaglandins in response to this agonist has not been examined. The presence of histamine receptors in epidermis has been shown by earlier work demonstrating that keratinocyte adenylate cyclase is stimulated via an H2 receptor (31, 32). To our knowledge, the capacity of keratinocytes to release prostaglandins through stimulation of H1 receptors is clearly demonstrated here for the first time.
A role for histamine in the erythema response to UVB has been established in several animal models but not in humans. In studies of guinea pigs, the early phase of erythema is sup-
